Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tick-Borne Diseases”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Large-scale testing (Phase 3)Study completedNCT00161746
What this trial is testing

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableLooking for participantsNCT07274046
What this trial is testing

Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic

Who this might be right for
Tick Borne Encephalitis (TBE)
Charles University, Czech Republic 209
Not applicableStudy completedNCT00594997
What this trial is testing

A School-Based Intervention to Reduce Lyme Disease

Who this might be right for
Lyme Disease
Brigham and Women's Hospital 3,570
Large-scale testing (Phase 3)Looking for participantsNCT07500506
What this trial is testing

Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

Who this might be right for
Lyme Disease
Pfizer 1,712
Early research (Phase 1)Study completedNCT06684431
What this trial is testing

Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever

Who this might be right for
Crimean Congo Hemorrhagic Fever
Karolinska Institutet 15
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Not applicableActive Not RecruitingNCT06835075
What this trial is testing

Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato

Who this might be right for
Lyme Borreliosis
University Medical Centre Ljubljana 15,000
Not applicableNot Yet RecruitingNCT06045481
What this trial is testing

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

Who this might be right for
Relapsing Fever, Tick-Borne
Medical Corps, Israel Defense Force 526
Not applicableStudy completedNCT04867473
What this trial is testing

Feasibility of Teleyoga for Treatment of Lyme Disease

Who this might be right for
Lyme Disease
Stanford University 15
Post-approval studies (Phase 4)Study completedNCT01562444
What this trial is testing

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Who this might be right for
Tick Borne EncephalitisVirus Diseases
GlaxoSmithKline 206
Large-scale testing (Phase 3)Study completedNCT01361776
What this trial is testing

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 200
Post-approval studies (Phase 4)Study completedNCT01106482
What this trial is testing

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Who this might be right for
Tick Borne Encephalitis (TBE)
Novartis Vaccines 126
Early research (Phase 1)Not Yet RecruitingNCT07377253
What this trial is testing

First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.

Who this might be right for
The Tick-borne Encephalitis Virus (TBEV)
Giuseppe Pantaleo 18
Very early researchLooking for participantsNCT06611111
What this trial is testing

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

Who this might be right for
Post-Treatment Lyme Disease
State University of New York - Upstate Medical University 44
Testing effectiveness (Phase 2)Study completedNCT05975099
What this trial is testing

Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age

Who this might be right for
Lyme Disease
ModernaTX, Inc. 807
Not applicableStudy completedNCT03371563
What this trial is testing

Erythema Migrans in Elderly

Who this might be right for
Lyme DiseaseErythema MigransElderly Infection
University Medical Centre Ljubljana 1,220
Early research (Phase 1)Looking for participantsNCT06799013
What this trial is testing

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

Who this might be right for
VaccineCrimean-Congo Hemorrhagic Fever
HDT Bio 48
Not applicableStudy completedNCT03956212
What this trial is testing

Inflammatory Mediators in Erythema Migrans

Who this might be right for
Erythema Migrans
University Medical Centre Ljubljana 150
Large-scale testing (Phase 3)Study completedNCT00001101
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease

Who this might be right for
Lyme Disease
National Institute of Allergy and Infectious Diseases (NIAID) 194
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation